Stay updated on JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page.

Latest updates to the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page
- ChecktodayChange DetectedRevision: v3.5.3 was added, replacing the previous v3.5.2. This update denotes a new site release and affects only the version tag shown on the page.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedLatest version adds/updates the Study Status in the record history (Revision: v3.5.2, dated 2026-04-13). The prior revision was v3.5.0 (dated 2026-03-13).SummaryDifference0.3%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedVersion 43 was submitted on 2026-03-12 with a Study Status update; the revision was updated to v3.5.0 on 2026-03-13, replacing the earlier v3.4.3 revision.SummaryDifference0.3%

- Check50 days agoChange DetectedAdded Revision v3.4.3 to the history and removed Revision v3.4.2, updating the record's revision history. This update reflects internal version tracking rather than substantive changes to study data.SummaryDifference0.1%

- Check72 days agoChange DetectedA new version entry (Version 42) was added on 2026-02-12, and a Study Status update was recorded on 2026-02-13. These additions update the visible status information in the study's record history.SummaryDifference0.2%

- Check79 days agoChange DetectedA new site revision (v3.4.2) was added and the temporary government-funding notice (and older revision v3.4.1) was removed. There is no impact on study data, content, or access to the records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page.